UZ Leuven
Leuven, Belgium
Location status: Recruiting
Location contact
Jan Tack, Prof., MD
CONTACT
NCT Number: NCT05808036
The aim of this study is to evaluate whether the DOMINO diet application is an effective tool in the treatment of Irritable bowel syndrome in tertiary care. Furthermore, this study aims to determine the response rate of the strict low FODMAP diet in non-responders to the DOMINO diet.
Interested in participating?
Request Info18 year–70 year
All sexes
Interventional
Not applicable
Leuven, Belgium
Location status: Recruiting
Jan Tack, Prof., MD
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Life style intervention and diet low in FODMAPs.
Strict low FODMAP diet.
Time frame: 18 months
The symptom response is measured by the Irritable Bowel Syndrome Symptom Severity Scale (IBS-SSS). In this questionnaire, each question (5) is scored from 0-100, with a maximum total score of 500. Improvement is defined as a 50-point or more drop on the IBS-SSS. The score is positively correlated with severity of IBS symptoms, a score from 50-175 indicated mild disease, 175-300 moderate and >300 severe.
Contact information is provided by the study sponsor or research team.
Universitaire Ziekenhuizen KU Leuven
Other
The Efficacy of the DOMINO Diet Application Versus the Low FODMAP Diet in Tertiary Care IBS Patients
Acronym: EDDI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06801184
Colonic Diseases, Colonic Diseases, Functional
Lyon, France
View Trial DetailsNCT07545772
Colonic Diseases, Colonic Diseases, Functional
Mesa, Arizona, United States
View Trial DetailsNCT07545759
Colonic Diseases, Colonic Diseases, Functional
Mesa, Arizona, United States
View Trial DetailsNCT06413004
Colonic Diseases, Colonic Diseases, Functional
Gothenburg, Sweden
View Trial Details